Allianz Global Benefits (AGB), the employee benefits network of Allianz Group, in December 2020 announced the appointment of Frank Forster as Managing Director and Chief Transformation Officer. According to the company, “Forster’s responsibility will include introducing new digital offerings to meet the growing demand of multinational corporate clients while implementing AGB’s holistic business model, organized as an employee benefits platform, to simplify and digitize the business.” In a statement,

Over the past nine months, the word “uncertainty” has cropped up time and time again across the news and social media worldwide. The pandemic has created uncertainty in nearly every aspect of daily life. This is not only down to worries over exposure to COVID-19 and access to medical care, but also concerns about the stability of the economy, job security, the availability of food and household supplies – and even when to book a holiday. We have needed to adjust and readjust our behaviour continually in response to changing risks and government guidelines.

In our daily life, we unfortunately have become used to seeing images of tumors and melanomas. You may have noticed that they’re are not entirely symmetric. This asymmetry is useful to doctors in their diagnoses, but why are they asymmetric?

As the weather cools, the number of infections of the COVID-19 pandemic are rising sharply. Hamstrung by pandemic fatigue, economic constraints and political discord, public health officials have struggled to control the surging pandemic. But now, a rush of interim analyses from pharmaceutical companies Moderna and Pfizer/BioNTech have spurred optimism that a novel type of vaccine made from messenger RNA, known as mRNA, can offer high levels of protection by preventing COVID-19 among people who are vaccinated.